The overall incidence of withdrawal movements due to rocuronium decreased significantly as the dose of dexmedetomidine increased ( 92.8 % , 85.2 % , 78.6 % , and 51.9 % in the saline , low-dose , subclinical dose , and clinical dose groups , respectively ; P = 0.001 ) .